3' End structure and rearrangements of EGFR in glioblastomas

Greg Eley, Lori Frederick, Xiao Yang Wang, David I Smith, C. David James

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Rearrangements of EGFR are known to occur in a significant fraction of glioblastomas, the most common and malignant form of central nervous system tumor. Although the consequences of these alterations have been described at the mRNA and protein level, little is known about human EGFR genomic sequence or organization at the rearrangement sites. To investigate one group of alterations in glioblastoma, we used long-range PCR to synthesize a segment of the gene near its 3' end, which is frequently rearranged in tumors with EGFR amplification. The sequence of this PCR product provided a precise map for the five 3'-terminal exons of EGFR, designated as exons 22-26. Ten tumors were identified with rearrangements in this part of the gene, most of which resulted in the loss of 325 coding bases that constitute exons 23-25. No two tumors shared identical donor or acceptor rearrangement sites, and the examination of sequences at these sites failed to support homologous recombination as a mechanism responsible for any of the rearrangements. However, examination of the entire exon 22-26 region for sequence motifs associated with genomic instability identified two large, CA-rich tracts in intron 25.

Original languageEnglish (US)
Pages (from-to)248-254
Number of pages7
JournalGenes Chromosomes and Cancer
Volume23
Issue number3
DOIs
StatePublished - Nov 1998

Fingerprint

Glioblastoma
Exons
Central Nervous System Neoplasms
Neoplasms
Polymerase Chain Reaction
Genomic Instability
Homologous Recombination
Introns
Genes
Messenger RNA
Proteins

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

3' End structure and rearrangements of EGFR in glioblastomas. / Eley, Greg; Frederick, Lori; Wang, Xiao Yang; Smith, David I; James, C. David.

In: Genes Chromosomes and Cancer, Vol. 23, No. 3, 11.1998, p. 248-254.

Research output: Contribution to journalArticle

Eley, Greg ; Frederick, Lori ; Wang, Xiao Yang ; Smith, David I ; James, C. David. / 3' End structure and rearrangements of EGFR in glioblastomas. In: Genes Chromosomes and Cancer. 1998 ; Vol. 23, No. 3. pp. 248-254.
@article{6e5bb6b52efe4e47959ea7b81dcfc097,
title = "3' End structure and rearrangements of EGFR in glioblastomas",
abstract = "Rearrangements of EGFR are known to occur in a significant fraction of glioblastomas, the most common and malignant form of central nervous system tumor. Although the consequences of these alterations have been described at the mRNA and protein level, little is known about human EGFR genomic sequence or organization at the rearrangement sites. To investigate one group of alterations in glioblastoma, we used long-range PCR to synthesize a segment of the gene near its 3' end, which is frequently rearranged in tumors with EGFR amplification. The sequence of this PCR product provided a precise map for the five 3'-terminal exons of EGFR, designated as exons 22-26. Ten tumors were identified with rearrangements in this part of the gene, most of which resulted in the loss of 325 coding bases that constitute exons 23-25. No two tumors shared identical donor or acceptor rearrangement sites, and the examination of sequences at these sites failed to support homologous recombination as a mechanism responsible for any of the rearrangements. However, examination of the entire exon 22-26 region for sequence motifs associated with genomic instability identified two large, CA-rich tracts in intron 25.",
author = "Greg Eley and Lori Frederick and Wang, {Xiao Yang} and Smith, {David I} and James, {C. David}",
year = "1998",
month = "11",
doi = "10.1002/(SICI)1098-2264(199811)23:3<248::AID-GCC7>3.0.CO;2-1",
language = "English (US)",
volume = "23",
pages = "248--254",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - 3' End structure and rearrangements of EGFR in glioblastomas

AU - Eley, Greg

AU - Frederick, Lori

AU - Wang, Xiao Yang

AU - Smith, David I

AU - James, C. David

PY - 1998/11

Y1 - 1998/11

N2 - Rearrangements of EGFR are known to occur in a significant fraction of glioblastomas, the most common and malignant form of central nervous system tumor. Although the consequences of these alterations have been described at the mRNA and protein level, little is known about human EGFR genomic sequence or organization at the rearrangement sites. To investigate one group of alterations in glioblastoma, we used long-range PCR to synthesize a segment of the gene near its 3' end, which is frequently rearranged in tumors with EGFR amplification. The sequence of this PCR product provided a precise map for the five 3'-terminal exons of EGFR, designated as exons 22-26. Ten tumors were identified with rearrangements in this part of the gene, most of which resulted in the loss of 325 coding bases that constitute exons 23-25. No two tumors shared identical donor or acceptor rearrangement sites, and the examination of sequences at these sites failed to support homologous recombination as a mechanism responsible for any of the rearrangements. However, examination of the entire exon 22-26 region for sequence motifs associated with genomic instability identified two large, CA-rich tracts in intron 25.

AB - Rearrangements of EGFR are known to occur in a significant fraction of glioblastomas, the most common and malignant form of central nervous system tumor. Although the consequences of these alterations have been described at the mRNA and protein level, little is known about human EGFR genomic sequence or organization at the rearrangement sites. To investigate one group of alterations in glioblastoma, we used long-range PCR to synthesize a segment of the gene near its 3' end, which is frequently rearranged in tumors with EGFR amplification. The sequence of this PCR product provided a precise map for the five 3'-terminal exons of EGFR, designated as exons 22-26. Ten tumors were identified with rearrangements in this part of the gene, most of which resulted in the loss of 325 coding bases that constitute exons 23-25. No two tumors shared identical donor or acceptor rearrangement sites, and the examination of sequences at these sites failed to support homologous recombination as a mechanism responsible for any of the rearrangements. However, examination of the entire exon 22-26 region for sequence motifs associated with genomic instability identified two large, CA-rich tracts in intron 25.

UR - http://www.scopus.com/inward/record.url?scp=0031708856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031708856&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2264(199811)23:3<248::AID-GCC7>3.0.CO;2-1

DO - 10.1002/(SICI)1098-2264(199811)23:3<248::AID-GCC7>3.0.CO;2-1

M3 - Article

VL - 23

SP - 248

EP - 254

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 3

ER -